Zhejiang Hisun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LOVASTATIN USP, with a corresponding US DMF Number 12133.
Remarkably, this DMF maintains an Active status since its submission on September 17, 1996, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 26, 2012, and payment made on November 15, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II